Descripción del producto

Product Name: MIRODENAFIL
Synonyms: MIRODENAFIL;*-Ethyl*3,*-dihydro**-[*-[[*-(*-hydroxyethyl)**-piperazinyl]sulfonyl]**-propoxyphenyl]**-propyl*4H-pyrrolo[3,*-d]pyrimidin**-one;4H-Pyrrolo[3,*-d]pyriMidin**-one,*-ethyl*3,*-dihydro**-[*-[[*-(*-hydroxyethyl)**-piperazinyl]sulfonyl]**-propoxyphenyl]**-propyl-;Mirodenafil, >=*8%
CAS: **********5
MF: C*6H*7N5O5S
MW: **1.**4 

Mirodenafil belongs to the drug class PDE5 inhibitors, which includes avanafil, sildenafil, tadalafil, udenafil, and vardenafil, and is the first-line treatment for erectile dysfunction. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the trade name Mvix, offered both as tablets (*0 mg and **0 mg) and as orally dissolving film (*0 mg).

Several clinical trials were conducted, but mirodenafil has not been approved for use in the United States by the U.S. Food and Drug Administration.